EUVIMEDEUVIMED entdecken
Crossref

Sex differences in chemotherapy-induced alopecia distress using the Japanese version of the Chemotherapy-Induced Alopecia Distress Scale

Hiroki Okumura, Shuko Soma, Yosuke Aoyama, Yu Harada, Yoshiko Yonejima, Kiyomi Nonogaki, Haruka Kono, Erisa Toda, Haruka Ozaki, Masahiro Kuno, Shogo Watanabe, Kazumasa Yamamoto und 8 weitere

Supportive Care in Cancer · 2026

DOI: 10.1007/s00520-026-11066-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Supportive Care in Cancer, 2026. Verfasst von Hiroki Okumura und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Alopecia, Antineoplastic Agents, Neoplasms, Stress, Psychological. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: While chemotherapy-induced alopecia (CIA) is a concern for patients with cancer, investigations involving men with CIA are limited. We aimed to examine sex differences in chemotherapy-related distress using the Japanese version of the Chemotherapy-Induced Alopecia Distress Scale (CADS-J). METHODS: The study, conducted at Toranomon and Yokohama Minami Kyosai Hospitals between March and December 2023, employed a one-time 17-item questionnaire survey (CADS-J) for patients with cancer who had not previously experienced CIA-related hair loss. Each item was scored from 0 (none) to 3 (severe), with total scores ranging from 0 to 51. RESULTS: Of 104 patients who received the questionnaire, 97 were included in the analysis (men, 55 [56.7%]; mean age, 62.6 ± 12.7 years). Metastatic disease was present in 92.7% and 50% of the men and women, respectively. Pancreatic (35%) and gastric (16%) cancers were most common in the men; while pancreatic (26%) and breast (24%) cancers were most common in the women. Common terminology criteria for adverse events (CTCAE) grade 2 CIA was observed in 70.9% and 95.2% of the men and women, respectively. Mean CADS-J total scores were: men, 5.7; women, 13.2 (p < 0.001); women scored significantly higher in every domain. In a multivariable analysis, female sex, wig or hat use, and depressive symptoms (Center for Epidemiologic Studies Depression Scale ≥ 16) were independently associated with higher CADS-J total scores. Among the men, 5/55 (9.1%) had CADS-J total scores ≥ 13 (the female mean); of whom four (80%) had CTCAE grade 2 CIA and wore a wig or hat. CONCLUSION: To our knowledge, this is the first study to report sex differences in distress associated with CIA using CADS-J. Distress was stronger in women, but some men also experienced marked distress. Further research and clinical evaluations are needed to individualize targeted care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlopeciaAntineoplastic AgentsNeoplasmsStress, PsychologicalAgedFemaleHumansMaleMiddle AgedJapanSex FactorsSurveys and QuestionnairesEast Asian People

Stichwörter der Autor:innen

CADS-JChemotherapy-induced alopeciaSex differences

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan.
  • Department of Pharmacy, Yokohama Minami Kyosai Hospital, Yokohama, Japan.
  • Breast Oncology Center, Breast Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan. yujmiura@mac.com.

Zitieren

APA

Okumura, H., Soma, S., Aoyama, Y., Harada, Y., Yonejima, Y., Nonogaki, K., Kono, H., Toda, E., Ozaki, H., Kuno, M., Watanabe, S., Yamamoto, K., Takemura, K., Yamaguchi, T., Tanabe, Y., Yokoyama, A., Uchino, K., Hashiguchi, K., Suyama, K., & Miura, Y. (2026). Sex differences in chemotherapy-induced alopecia distress using the Japanese version of the Chemotherapy-Induced Alopecia Distress Scale. Supportive Care in Cancer. https://doi.org/10.1007/s00520-026-11066-2

Vancouver

Okumura H, Soma S, Aoyama Y, Harada Y, Yonejima Y, Nonogaki K, et al. Sex differences in chemotherapy-induced alopecia distress using the Japanese version of the Chemotherapy-Induced Alopecia Distress Scale. Supportive Care in Cancer. 2026. doi:10.1007/s00520-026-11066-2

BibTeX
@article{Okumura2026,
  author = {Okumura, Hiroki and Soma, Shuko and Aoyama, Yosuke and Harada, Yu and Yonejima, Yoshiko and Nonogaki, Kiyomi and Kono, Haruka and Toda, Erisa and Ozaki, Haruka and Kuno, Masahiro and Watanabe, Shogo and Yamamoto, Kazumasa and Takemura, Kohji and Yamaguchi, Takeshi and Tanabe, Yuko and Yokoyama, Atsushi and Uchino, Keita and Hashiguchi, Koji and Suyama, Koichi and Miura, Yuji},
  title = {Sex differences in chemotherapy-induced alopecia distress using the Japanese version of the Chemotherapy-Induced Alopecia Distress Scale},
  journal = {Supportive Care in Cancer},
  year = {2026},
  doi = {10.1007/s00520-026-11066-2}
}
Kostenlos starten →